A district court ruled that the HHS does have the power to review drug manufacturers’ plans to pay hospitals rebates instead ...

Sanofi said it will invest at least $20 billion in the US through 2030, joining other pharmaceutical companies boosting their ...

A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...

Add Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald ...

France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the ...

Sanofi plans to invest $20 billion in U.S.-based drug R&D and manufacturing over five years, creating jobs and boosting ...

The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...

Novisto has secured $27 million in Series C funding to expand its corporate ESG tracking platform. The platform automates ...

The symposium highlighted the disproportionate impact of seasonal influenza on high-risk groups, particularly adults aged 65 ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Sanofi plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, joining ...

France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the ...